The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based liquid biopsy: A promising non-invasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma.
 
Alireza Ghoreifi
No Relationships to Disclose
 
Stephanie Shishido
No Relationships to Disclose
 
George Courcoubetis
No Relationships to Disclose
 
Salmaan Sayeed
No Relationships to Disclose
 
Amy Huang
No Relationships to Disclose
 
Anne K. Schuckman
Honoraria - pacific edge; Photocure
Consulting or Advisory Role - Fergene; Gerson Lehrman Group; Pacific Edge Biotechnology; Pacific Edge Biotechnology; Photocure
Speakers' Bureau - Photocure
 
Monish Aron
No Relationships to Disclose
 
Mihir Desai
No Relationships to Disclose
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; Ferring; Janssen Oncology; Johnson & Johnson; Olympus; pacific edge; Pfizer; Photocure; Protara Therapeutics; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Inderbir Gill
No Relationships to Disclose
 
Peter Kuhn
Stock and Other Ownership Interests - Cansera; Earli; Epic Sciences; forbie; Sampling Human
Consulting or Advisory Role - Epic Sciences
Research Funding - Abbvie; Amgen; Daiichi Sankyo; Fluidigm; Gilead Sciences; Kite, a Gilead company; Lilly; Novartis
Patents, Royalties, Other Intellectual Property - HDSCA liquid biopsy technology developed in the Kuhn laboratory initially at The Scripps Research Institute and subsequently at the University of Southern California and related patents have been licensed for commercial development to Epic Sciences.; Patent 62/783,921: "System and Method for Determining Human Performance". Systems and methods in human performance to determine whether a cancer patient will need unplanned medical care during cancer therapy.
 
Jeremy Mason
No Relationships to Disclose
 
Hooman Djaladat
No Relationships to Disclose